about
Inhibitory antibodies targeting emerging viruses: advancements and mechanismsAssembly of the murine leukemia virus is directed towards sites of cell-cell contactHIV-1 matrix dependent membrane targeting is regulated by Gag mRNA traffickingDirectional spread of surface-associated retroviruses regulated by differential virus-cell interactions.Basic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse.A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus.Murine leukemia virus Gag localizes to the uropod of migrating primary lymphocytesBroadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis.Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides.Virus cell-to-cell transmission.Surface Transmission or Polarized Egress? Lessons Learned from HTLV Cell-to-Cell Transmission.The lack of an inherent membrane targeting signal is responsible for the failure of the matrix (M1) protein of influenza A virus to bud into virus-like particles.Distinct intracellular trafficking of equine infectious anemia virus and human immunodeficiency virus type 1 Gag during viral assembly and budding revealed by bimolecular fluorescence complementation assays.Association of gag multimers with filamentous actin during equine infectious anemia virus assembly.Functions of early (AP-2) and late (AIP1/ALIX) endocytic proteins in equine infectious anemia virus budding.Antiviral Functions of Monoclonal Antibodies against Chikungunya Virus
P50
Q24289645-800F7D4F-A528-4832-951D-CFD51A756E5FQ27329731-344F458A-B080-455F-9359-3F34905B53F4Q27345288-D303E2BB-7AFC-41F8-92CE-E8ECF37C221AQ30493648-2F6539AB-9D1E-4197-A94D-40CCD0CC8890Q30540433-17242608-6F1E-4C1C-A6AE-4306715598D4Q33367007-514882EF-8935-4797-BAF2-1B44BA10C2B5Q34262061-1DC73997-EE16-4DD1-AB63-85A4A3B51BA6Q36318652-68AA138E-7CD7-4AB1-AF7C-E647D2516329Q36483436-13F1B145-7CFA-433D-94BB-23A666B6EC4CQ36949766-131981B6-A2BF-433F-A114-4C0FCDA8D2C4Q37726587-7BBD5BEC-1656-4032-8F46-C71380A82B91Q38614477-99734FAA-8F75-4432-8301-DAC6DB04A22CQ39735600-AAF83EA0-83E3-4EF0-8615-C901EBA82E3FQ40096523-6F39033D-1851-433D-84CE-1E831C832FF1Q45403977-D8B657C0-D6A4-4011-BF5D-071E4CE94A79Q45423391-2B21D8AD-78BB-4328-8214-D522283BFBBDQ66680697-E466398B-200C-4608-B4A1-2B35FDEC7365
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0003-3994-8600
@en
name
Jing Jin
@ast
Jing Jin
@en
Jing Jin
@es
Jing Jin
@nl
Jing Jin
@sl
type
label
Jing Jin
@ast
Jing Jin
@en
Jing Jin
@es
Jing Jin
@nl
Jing Jin
@sl
prefLabel
Jing Jin
@ast
Jing Jin
@en
Jing Jin
@es
Jing Jin
@nl
Jing Jin
@sl
P106
P1153
36477222400
56972998900
P31
P496
0000-0003-3994-8600